News: WuXi PharmaTech (Cayman) Inc. (WX.N)
16.52USD
4:03pm EST
$-0.42 (-2.48%)
$16.94
$17.00
$17.05
$16.40
148,100
348,961
$18.00
$3.67
Thu, Sep 3 2009
China's drug contractors on a fast-growth track
NEW YORK, Sept 3 (Reuters) - Companies that conduct research for drugmakers are poised for torrid growth in China as their multinational clients look to sell more medicines in the world's most populous country and cut development costs.
HEADLINE STOCKS-Some U.S. stocks on the move on Aug. 12
(Updates to afternoon trading, adds Mindray Medical, WuXi, Commercial Vehicle, Ethan Allen. AstraZeneca/Forest Labs, ADC Telecommunications. Delta/US Airways)
US RESEARCH SUMMARY-Non-S&P 500 March 27 1713 GMT
Following is a summary of research actions on non-S&P 500 companies reported
US RESEARCH SUMMARY-Non-S&P 500 March 27 1454 GMT
Following is a summary of research actions on non-S&P 500 companies reported
ADR Report-GE, drugs and banks lift foreign stocks
NEW YORK, March 12 (Reuters) - Overseas shares traded in the United States rose on Thursday as S&P's downgrade of General Electric's debt rating was perceived as good news and a pharmaceutical takeover sent drug makers' ADRs higher.
US-RESEARCH/ (NON-S&P500)
Lecg UBS Cuts to neutral from buy; price
US-RESEARCH/ (NON-S&P500)
--------------------------------------------------------------- - ----------- Werner Enterprises Credit Suisse Starts with underperform rating; price target $18; reports
WuXi shares drop as Covance China JV falls through
BANGALORE (Reuters) - Shares of WuXi PharmaTech , China's biggest pharmaceutical research outsourcing firm, fell 21 percent to a 52-week low after the company and clinical testing firm Covance Inc parted ways on a joint venture to provide preclinical contract research services in China.
WuXi shares drop as Covance China JV falls through
BANGALORE (Reuters) - Shares of WuXi PharmaTech , China's biggest pharmaceutical research outsourcing firm, fell 21 percent to a 52-week low after the company and clinical testing firm Covance Inc parted ways on a joint venture to provide preclinical contract research services in China.
Providence Equity hires HK-based managing director
SHANGHAI, Sept 16 (Reuters) - Providence Equity Partners will hire General Atlantic Managing Director Sean Tong as a managing director in Hong Kong as it moves to bolster dealmaking opportunities in China, the U.S. buyout firm said on Tuesday.
Press Releases
- WuXi PharmaTech Selects Labcyte POD(TM) 810 Platform for High-Throughput Screening
- WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year
- WuXi PharmaTech Announces Third-Quarter 2009 Results
- WuXi AppTec Receives 2009 Schering-Plough Excellence Award
- WuXi PharmaTech Schedules Third-Quarter 2009 Earnings Release





